Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Insys ‘Reimbursement Unit’ Fraudulently Boosted Fentanyl Rxs, DOJ Charges

Dec 09 2016

• By Brenda Sandburg

BusinessmanBehindBars_1200-x-675

Related Content

Tarceva Off-Label Marketing Caused 'Earlier' Death, DOJ Alleged

Jun 10 2016

Acquittal Of Former Warner Chilcott Exec May Make Future Prosecutions More Difficult

Jun 18 2016

Related Companies

INSYS Therapeutics, Inc.

Warner Chilcott PLC

Allergan plc

Additional Topics

United States Policy Legal Issues Reimbursement BioPharmaceutical

More from Legal & IP

More from Pink Sheet

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.